Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Mosnaim

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Diabetes|May 1, 1979
Reduced monoamine oxidase activity in blood platelets from insulin-dependent diabetic subjectsA D Mosnaim, M E Wolf, S Huprikar, et al.
The Journal of Clinical Psychiatry|September 1, 1985
Vulnerability to tardive dyskinesiaM E Wolf, A S DeWolfe, J J Ryan, et al.
Life Sciences|January 1, 1974
Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinolH C Sabelli, W A Pedemonte, C Whalley, et al.
Journal of Chromatographic Science|December 1, 1983
Plasma and cerebrospinal fluid concentration of phenylacetic acid in humans and monkeysF Karoum, L W Chuang, A D Mosnaim, et al.
International Immunopharmacology|July 20, 2001
Effect of Salmonella-infected human monocytes on natural killer cell cytotoxicity. In vitro studiesL Blanco, J Puente, C Carrasco, et al.
Brain, Behavior, and Immunity|March 1, 1992
Enhancement of human natural killer cell activity by opioid peptides: similar response to methionine-enkephalin and beta-endorphinJ Puente, P Maturana, D Miranda, et al.
American Journal of Therapeutics|April 24, 2001
Degradation kinetics of leucine5-enkephalin by plasma samples from healthy controls and various patient populations: in vitro drug effectsA D Mosnaim, M E Wolf, T D Nguyen, et al.
Journal of Clinical Psychopharmacology|October 28, 1998
Lithium, hypercalcemia, and arrhythmiaM E Wolf, M Moffat, V Ranade, et al.
General Pharmacology|January 1, 1988
Studies of the in vitro human plasma degradation of methionine-enkephalinA D Mosnaim, J Puente, M E Wolf, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
Activation of protein tyrosine kinase: a possible requirement for fixed-bacteria and lipopolysaccharide-induced increase in human natural killer cell activityJ Puente, M A Salas, C Canon, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Diabetes|May 1, 1979
Reduced monoamine oxidase activity in blood platelets from insulin-dependent diabetic subjectsA D Mosnaim, M E Wolf, S Huprikar, et al.
The Journal of Clinical Psychiatry|September 1, 1985
Vulnerability to tardive dyskinesiaM E Wolf, A S DeWolfe, J J Ryan, et al.
Life Sciences|January 1, 1974
Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinolH C Sabelli, W A Pedemonte, C Whalley, et al.
Journal of Chromatographic Science|December 1, 1983
Plasma and cerebrospinal fluid concentration of phenylacetic acid in humans and monkeysF Karoum, L W Chuang, A D Mosnaim, et al.
International Immunopharmacology|July 20, 2001
Effect of Salmonella-infected human monocytes on natural killer cell cytotoxicity. In vitro studiesL Blanco, J Puente, C Carrasco, et al.
Brain, Behavior, and Immunity|March 1, 1992
Enhancement of human natural killer cell activity by opioid peptides: similar response to methionine-enkephalin and beta-endorphinJ Puente, P Maturana, D Miranda, et al.
American Journal of Therapeutics|April 24, 2001
Degradation kinetics of leucine5-enkephalin by plasma samples from healthy controls and various patient populations: in vitro drug effectsA D Mosnaim, M E Wolf, T D Nguyen, et al.
Journal of Clinical Psychopharmacology|October 28, 1998
Lithium, hypercalcemia, and arrhythmiaM E Wolf, M Moffat, V Ranade, et al.
General Pharmacology|January 1, 1988
Studies of the in vitro human plasma degradation of methionine-enkephalinA D Mosnaim, J Puente, M E Wolf, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1996
Activation of protein tyrosine kinase: a possible requirement for fixed-bacteria and lipopolysaccharide-induced increase in human natural killer cell activityJ Puente, M A Salas, C Canon, et al.
Pageof 8